Literature DB >> 17562625

Eosinophils derived from acute promyelocytic leukemia cells after arsenic trioxide treatment.

Kazuhito Yamamoto, Nobuhiko Emi, Tomohiro Kajiguchi, Shunji Yamamori, Yoshitaka Ono, Tomoki Naoe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17562625     DOI： 10.1532/IJH97.06225

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  8 in total

Review 1.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

Authors:  A Melnick; J D Licht
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

2.  Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.

Authors:  K Kitamura; Y Minami; K Yamamoto; Y Akao; H Kiyoi; H Saito; T Naoe
Journal:  Leukemia       Date:  2000-10       Impact factor: 11.528

3.  Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukemia cell line with t(15;17).

Authors:  K Kishi; K Toba; T Azegami; N Tsukada; Y Uesugi; M Masuko; H Niwano; S Hashimoto; M Sakaue; T Furukawa; T Koike; H Takahashi; T Maekawa; T Abe; Y Aizawa
Journal:  Exp Hematol       Date:  1998-02       Impact factor: 3.084

4.  Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.

Authors:  L H Camacho; S L Soignet; S Chanel; R Ho; G Heller; D A Scheinberg; R Ellison; R P Warrell
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

5.  The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene.

Authors:  T B van Dijk; E Caldenhoven; J A Raaijmakers; J W Lammers; L Koenderman; R P de Groot
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

6.  Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

Authors:  G Q Chen; X G Shi; W Tang; S M Xiong; J Zhu; X Cai; Z G Han; J H Ni; G Y Shi; P M Jia; M M Liu; K L He; C Niu; J Ma; P Zhang; T D Zhang; P Paul; T Naoe; K Kitamura; W Miller; S Waxman; Z Y Wang; H de The; S J Chen; Z Chen
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

7.  Clonal analysis of the response of HL60 human myeloid leukemia cells to biological regulators.

Authors:  D Metcalf
Journal:  Leuk Res       Date:  1983       Impact factor: 3.156

8.  Dysplastic eosinophils in three patients with acute promyelocytic leukaemia.

Authors:  K Ghosh; N Varma; S Dash
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.